Literature DB >> 20039082

Conversion of atrial flutter to sinus rhythm during landiolol infusion.

Shunsuke Yamamoto1, Koji Goto, Yoshifumi Ohchi, Norihisa Yasuda, Chihiro Shingu, Takayuki Noguchi.   

Abstract

A 73-year-old male patient with a past history of hypertension and atrial premature contraction underwent endoscopic restoration of the left bubonocele. Sinus rhythm was confirmed by preoperative electrocardiography, but paroxysmal atrial flutter developed when abdominoscopy was started. Continuous administration of landiolol hydrochloride at a dose of 0.005 mg kg(-1) min(-1) after a loading dose of 0.04 mg kg(-1) min(-1) for 1 min resulted in control of heart rate without a decrease in blood pressure. Atrial flutter was converted to sinus rhythm 3 min after the start of administration. Landiolol hydrochloride was administered continuously until the morning of the following day and sinus rhythm was maintained postoperatively.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20039082     DOI： 10.1007/s00540-009-0824-6

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


  15 in total

1.  Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101.

Authors:  S Iguchi; H Iwamura; M Nishizaki; A Hayashi; K Senokuchi; K Kobayashi; K Sakaki; K Hachiya; Y Ichioka; M Kawamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-06       Impact factor: 1.645

2.  Conversion of atrial fibrillation to sinus rhythm during landiolol infusion.

Authors:  Taku Mayahara; Maria Goto; Mikako Sato; Takeshi Kanazawa; Shinji Isomine; Hiroshi Nakajima; Koji Sakaida
Journal:  J Anesth       Date:  2004       Impact factor: 2.078

3.  ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliott Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Anesth Analg       Date:  2008-03       Impact factor: 5.108

4.  Effects of esmolol on patients with left ventricular dysfunction.

Authors:  A S Iskandrian; C E Bemis; A H Hakki; I Panidis; J Heo; J G Toole; T A Hua; D Allin; S Kane-Marsch
Journal:  J Am Coll Cardiol       Date:  1986-07       Impact factor: 24.094

Review 5.  Management of atrial flutter.

Authors:  M J Niebauer; M K Chung
Journal:  Cardiol Rev       Date:  2001 Sep-Oct       Impact factor: 2.644

6.  Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group.

Authors:  A Wallace; B Layug; I Tateo; J Li; M Hollenberg; W Browner; D Miller; D T Mangano
Journal:  Anesthesiology       Date:  1998-01       Impact factor: 7.892

7.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

8.  Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.

Authors:  Kazuyoshi Hirota; Sachiko Baba; Sadao Fukushi; Masatoshi Muraoka; Akitomo Matsuki
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

9.  Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.

Authors:  E V Platia; E L Michelson; J K Porterfield; G Das
Journal:  Am J Cardiol       Date:  1989-04-15       Impact factor: 2.778

10.  The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease.

Authors:  Koji Goto; Chihiro Shingu; Shinji Miyamoto; Hiroshi Miyakawa; Takayuki Noguchi
Journal:  J Clin Anesth       Date:  2007-11       Impact factor: 9.452
View more
  2 in total

1.  Alteration of fatal 1:1 conducted atrial flutter to less conducted ratio by landiolol infusion.

Authors:  Junko Takata; Naoko Haruyama; Tomoko Arashi; Tomoko Mae
Journal:  J Anesth       Date:  2016-04-16       Impact factor: 2.078

2.  Very-low-dose continuous drip infusion of landiolol hydrochloride for postoperative atrial tachyarrhythmia in patients with poor left ventricular function.

Authors:  Akimasa Morisaki; Mitsuharu Hosono; Yasuyuki Sasaki; Hidekazu Hirai; Masanori Sakaguchi; Atsushi Nakahira; Hiroyuki Seo; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.